IVN-CAT-001A Performance of CAST With Different Allergens in Patients With Cat Dander Allergy

This study has been completed.
Sponsor:
Collaborator:
ImVision AG
Information provided by:
University of Zurich
ClinicalTrials.gov Identifier:
NCT00620880
First received: February 11, 2008
Last updated: November 19, 2008
Last verified: November 2008
  Purpose

Primary objective of the trial:

To determine at which concentration the fusion protein MAT Fel d1 degranulates basophils of cat dander allergic patients, in comparison to a cat dander extract and to Fel d1 alone


Condition Intervention
Allergy to Cats
Behavioral: Blood sample

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Performance of CAST With Different Allergens in Patients With Cat Dander Allergy

Resource links provided by NLM:


Further study details as provided by University of Zurich:

Study Start Date: September 2005
Study Completion Date: September 2006
  Eligibility

Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion criteria: 1. Patient with Cat Dander Allergy evidenced by positive history 2. Age: 18 to 75 years

Exclusion criteria: 1. Use of oral corticosteroids, Chromoglycin, Ketotifen, or any immunosuppressive drugs within the last 2 months 2. Psychiatric disorder resulting in malcompliance 3. Neg. IgE to Cat dander

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00620880

Locations
Switzerland
Zurich, Switzerland
Sponsors and Collaborators
University of Zurich
ImVision AG
Investigators
Study Director: 01 Studienregister MasterAdmins UniversitaetsSpital Zuerich
  More Information

No publications provided

Responsible Party: University Hospital Zürich, University of Zurich
ClinicalTrials.gov Identifier: NCT00620880     History of Changes
Other Study ID Numbers: IVN-CAT-001A
Study First Received: February 11, 2008
Last Updated: November 19, 2008
Health Authority: Switzerland: Swissmedic

Additional relevant MeSH terms:
Hypersensitivity
Immune System Diseases

ClinicalTrials.gov processed this record on July 22, 2014